These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 11845456)

  • 1. Recommendations for fungal opportunistic infections prevention in persons infected with human immunodeficiency virus.
    Popa LG; Popa MI; Zaharia A; Ocneanu M
    Roum Arch Microbiol Immunol; 1999; 58(2):185-95. PubMed ID: 11845456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can OI prophylaxis be stopped in patients responding to HAART?
    Boyle BA
    AIDS Read; 1999 Jul; 9(4):240-2, 245. PubMed ID: 12737113
    [No Abstract]   [Full Text] [Related]  

  • 4. Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough?
    Lynen L; Jacobs J; Colebunders R
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1059-60. PubMed ID: 17662321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in HIV/AIDS therapy.
    Johnson SC; Gerber JG
    Adv Intern Med; 2000; 45():1-40. PubMed ID: 10635044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotrimoxazole prophylaxis in HIV-infected pregnant women: only a first step.
    Heather Watts D; Mofenson LM
    J Infect Dis; 2006 Dec; 194(11):1478-80. PubMed ID: 17083031
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic infections and HIV.
    Ioannidis J; Wilkinson D
    Clin Evid; 2002 Jun; (7):717-37. PubMed ID: 12230699
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphous hemangioendothelioma in a child with acquired immunodeficiency syndrome (AIDS).
    Paul SR; Hurford MT; Miettinen MM; Aronoff SC; Delvecchio M; Grewal H; Tuluc M
    Pediatr Blood Cancer; 2008 Mar; 50(3):663-5. PubMed ID: 16991137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital.
    Shen YZ; Qi TK; Ma JX; Jiang XY; Wang JR; Xu QN; Huang Q; Liu XN; Sun HQ; Lu HZ
    Mycoses; 2007 Nov; 50(6):475-80. PubMed ID: 17944709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.
    Clin Infect Dis; 1995 Aug; 21 Suppl 1():S32-43. PubMed ID: 8547510
    [No Abstract]   [Full Text] [Related]  

  • 15. Declining gastrointestinal opportunistic infections in HIV-infected persons: a triumph of science and a challenge for our HAARTs and minds.
    Raufman JP
    Am J Gastroenterol; 2005 Jul; 100(7):1455-8. PubMed ID: 15984965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of opportunistic infections in HIV-infected adults].
    Furrer H; Malinverni R
    Ther Umsch; 1998 May; 55(5):302-9. PubMed ID: 9643128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and treatment of opportunistic infections].
    Nevot Falcó S; Bartralot Soler J
    Allergol Immunopathol (Madr); 1998; 26(3):144-50. PubMed ID: 9675398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.
    Louie JK; Hsu LC; Osmond DH; Katz MH; Schwarcz SK
    J Infect Dis; 2002 Oct; 186(7):1023-7. PubMed ID: 12232845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
    Brooks JT; Kaplan JE; Masur H
    Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotrimoxazole prophylaxis in HIV-infected individuals after completing anti-tuberculosis treatment in Thyolo, Malawi.
    Zachariah R; Spielmann MP; Harries AD; Gomani P; Bakali E
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1046-50. PubMed ID: 12546111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.